Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-02-28 @ 7:10 AM
Study NCT ID:
NCT02620306
Status:
COMPLETED
Last Update Posted:
2022-05-25
First Post:
2015-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
Sponsor:
Boryung Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BR-FMS-CT-303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None